NCT06828380View on ClinicalTrials.gov

A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion

PHASE2RecruitingINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

August 6, 2028

Study Completion Date

August 6, 2028

Conditions

Advanced Hepatocellular Carcinoma (HCC)

Interventions

RADIATION

Particle beam radiation therapy

The prescribed dose and fractionation for proton therapy to the PTV will be determined by the physician, taking into account the dose-volume constraints of normal tissues such as the liver and bowel.

Trial Locations (1)

Unknown

RECRUITING

National Cancer Center, Goyang

All Listed Sponsors

lead

National Cancer Center, Korea

OTHER_GOV